您的位置: 首页 > 农业专利 > 详情页

Utilisation d inhibiteurs peptidiques auxquels les cellules sont perméables de la voie de transduction de signaux JNK pour le traitement de diverses maladies
专利权人:
XIGEN INFLAMMATION LTD.
发明人:
申请号:
EP12000663.0
公开号:
EP2489361B1
申请日:
2009.06.02
申请国别(地区):
EP
年份:
2014
代理人:
摘要:
The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of various diseases or disorders strongly related to JNK signaling, wherein these diseases or disorders are selected from autoimmune disorders, cardiovascular diseases, cancerous diseases, diabetes, including diabetes type 1 or type 2, inflammatory diseases, hair loss, including Alopecia areata, diseases of the lung, neuronal or neurodegenerative diseases, diseases of the liver, diseases of the spine, diseases of the uterus, viral infectious diseases and depressive disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充